CytomX Therapeutics Inc. (NASDAQ: CTMX) Stock Information | RedChip

CytomX Therapeutics Inc. (NASDAQ: CTMX)


$1.1000
+0.0100 ( +3.77% ) 445.8K

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Market Data


Open


$1.1000

Previous close


$1.0900

Volume


445.8K

Market cap


$84.91M

Day range


$1.0650 - $1.1940

52 week range


$0.8330 - $5.8500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 07, 2024
10-q Quarterly Reports 62 Nov 07, 2024
4 Insider transactions 1 Aug 22, 2024
4 Insider transactions 1 Aug 22, 2024
4 Insider transactions 1 Aug 22, 2024
4 Insider transactions 1 Aug 22, 2024
4 Insider transactions 1 Aug 22, 2024
8-k 8K-related 12 Aug 08, 2024
10-q Quarterly Reports 62 Aug 08, 2024
8-k 8K-related 13 Jun 17, 2024

Latest News